What Clover Health Investments, Corp.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 18 | 42 |
| Total trades | 22 | 99 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 99 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Soares Karen | Chief Legal Officer | Oct 20 | Disclosed 10b5-1 sale · S | −19,275 | $4.66 | −$89.8K | 1,573,423 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Oct 19 | Disclosed 10b5-1 sale · S | −4,066 | $4.41 | −$17.9K | 2,770,351 |
| Thornton Joseph Clay | Interim CFO | Oct 15 | Sale for tax withholding · S | −4,591 | $4.68 | −$21.5K | 1,244,935 |
| Toy Andrew | Chief Executive Officer | Oct 15 | Sale for tax withholding · S | −62,176 | $4.68 | −$291K | 9,078,334 |
| Wai Conrad | CEO, Counterpart Health | Oct 15 | Sale for tax withholding · S | −23,627 | $4.68 | −$111K | 1,042,072 |
| Soares Karen | Chief Legal Officer | Oct 15 | Sale for tax withholding · S | −14,673 | $4.68 | −$68.7K | 1,592,698 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Oct 15 | Sale for tax withholding · S | −18,273 | $4.68 | −$85.5K | 2,774,417 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Oct 07 | Disclosed 10b5-1 sale · S | −2,006 | $4.63 | −$9.29K | 2,792,690 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Oct 05 | Sale for tax withholding · S | −8,750 | $4.42 | −$38.7K | 2,794,696 |
| Toy Andrew | Chief Executive Officer | Oct 01 | Sale for tax withholding · S | −318,806 | $4.19 | −$1.34M | 9,140,510 |
| Torricelli Robert G | Director | Sep 30 | Grant / award · A | +12,481 | — | — | 186,897 |
| Miller Brian James | Director | Sep 30 | Grant / award · A | +12,481 | — | — | 12,481 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sep 17 | Disclosed 10b5-1 sale · S | −1,921 | $4.56 | −$8.76K | 2,803,446 |
| Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sep 16 | Sale for tax withholding · S | −3,170 | $4.64 | −$14.7K | 275,897 |
| Reynoso Jamie L. | CEO, Medicare Advantage | Sep 15 | Sale for tax withholding · S | −9,273 | $4.78 | −$44.3K | 2,805,367 |
| Soares Karen | Chief Legal Officer | Sep 15 | Sale for tax withholding · S | −6,846 | $4.78 | −$32.7K | 1,607,371 |
| Wai Conrad | CEO, Counterpart Health | Sep 15 | Disclosed 10b5-1 sale · S | −300,000 | $4.72 | −$1.42M | 1,170,056 |
| Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sep 14 | Open-market sale · S | −20,000 | $5.16 | −$103K | 279,067 |
| Thornton Joseph Clay | Interim CFO | Aug 17 | Sale for tax withholding · S | −17,775 | $4.39 | −$78K | 1,249,526 |
| Thornton Joseph Clay | Interim CFO | Aug 12 | Grant / award · A | +54,347 | — | — | 1,267,301 |
Loading...
